Insights
Insights From Our Experts
Articles
The Evolution of Digital Health Policy: A 2024 Retrospective and 2025 Outlook
The landscape of digital health policy continues to evolve, with significant advancements shaping the regulatory and reimbursement frameworks. Here are some of the key developments that occurred during 2024 as well as our predictions for what…
Patient Centric 3.0: Why a Direct-to-Patient Model Is a Game Changer
At the Frontiers Health 2024 event, Scott Snyder, EVERSANA’s Chief Digital Officer, led a panel discussion titled “Patient Centric 3.0: Why a Direct-to-Patient Model Is a Game Changer,” where industry experts explained the transformative impact of…
AI, Digital Therapeutics Transformation & Cross-Industry Collaboration – What’s On Tap at Frontiers Health
Frontiers Health global conference is just a few weeks away, and as founder and chairman of the event, it’s a special few days. Every year, Frontiers Health explores the most relevant health topics, leading the way…
Digital Therapeutics: A Necessity for Italy – Insights from Roberto Ascione and Alberta Spreafico
A Collaborative Approach to Integrating Digital Therapeutics (DTx) into the Italian Health System Roberto Ascione, our President, Health Innovation, and Alberta Spreafico, PhD, MBA, Senior Vice President, Health Innovation, have co-authored the Italian publication “Digital Therapeutics:…
The Future of Global Commercialization: Unified, Data-Driven and Patient-Centric
Are you interested in the rapidly evolving pharmaceutical landscape? Do you want to understand the paradigm shift in global commercialization strategies? If so, we have just the resource for you! Download our latest article titled “The…
EVERSANA Experts On-Stage at Frontiers Health 2024
In anticipation of Frontiers Health 2024, EVERSANA is delighted to reveal that several of our key experts will be speaking at this top-tier global health innovation conference! Scheduled for October 17-18th in Berlin, Germany, Frontiers Health…
EVERSANA’s Commitment to Health Innovation in Europe: Leading the Charge at Frontiers Health 2024
EVERSANA is leading conversations about next-generation commercialization as the presenting sponsor at the global health innovation event Frontiers Health 2024. As we expand our global reach in Europe and beyond, Frontiers Health represents the perfect event…
PDURS Explained: The FDA’s New Framework for Adding Software to Drug Labels
The U.S. FDA has recently proposed a new draft framework that enables pharma manufacturers to add software to a drug label if they can demonstrate that the software adds clinical benefit to the drug. This prescription…
Demystifying the New Prescription Drug Use-Related Software Framework
Authors: Martin Culjat, PhD , Kory Dillman and Scott Kellogg The Food and Drug Administration (FDA) unveiled its draft guidance on Regulatory Considerations for Prescription Drug Use-Related Software (PDURS) in September 2023. The document shed light on how the…
Harnessing the Commercial Promise of Prescription Drug Use-Related Software (PDURS)
Posted by John Kutz , Martin Culjat, PhD , Justin Averback , Calvin Fujimoto , Joey Pecoraro on March 7, 20243/7/24
The FDA’s draft guidance on Prescription Drug Use-Related Software (PDURS) offers pharmaceutical manufacturers a novel strategy to enhance a drug’s label by enabling an HCP to prescribe software alongside the drug at the HCP’s discretion. The…